Traders purchased shares of Thermo Fisher Scientific Inc. (NYSE:TMO) on weakness during trading on Thursday. $74.43 million flowed into the stock on the tick-up and $53.69 million flowed out of the stock on the tick-down, for a money net flow of $20.74 million into the stock. Of all equities tracked, Thermo Fisher Scientific had the 18th highest net in-flow for the day. Thermo Fisher Scientific traded down ($0.08) for the day and closed at $158.82

A number of equities research analysts have recently issued reports on the company. Mizuho set a $175.00 price target on Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday. Citigroup Inc. upped their price target on Thermo Fisher Scientific from $160.00 to $182.00 and gave the company a “buy” rating in a research report on Friday. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Thursday, July 21st. BTIG Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price target for the company in a research report on Friday, July 22nd. Finally, Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Sunday, May 29th. Two analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $159.48.

The stock’s 50 day moving average is $151.81 and its 200 day moving average is $143.19. The company has a market cap of $62.57 billion and a price-to-earnings ratio of 31.79.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Thursday, July 28th. The company reported $2.03 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.01 by $0.02. During the same quarter in the prior year, the firm earned $1.84 earnings per share. The company had revenue of $4.54 billion for the quarter, compared to analyst estimates of $4.50 billion. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, equities analysts anticipate that Thermo Fisher Scientific Inc. will post $8.14 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Thursday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Tuesday, September 13th. This represents a $0.60 annualized dividend and a yield of 0.38%.

In other news, CAO Peter E. Hornstra sold 7,811 shares of the business’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $150.00, for a total transaction of $1,171,650.00. Following the completion of the sale, the chief accounting officer now directly owns 21,246 shares of the company’s stock, valued at approximately $3,186,900. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 30,000 shares of the business’s stock in a transaction on Friday, July 1st. The shares were sold at an average price of $148.85, for a total transaction of $4,465,500.00. Following the sale, the chief executive officer now directly owns 350,998 shares of the company’s stock, valued at $52,246,052.30. The disclosure for this sale can be found here.

Several hedge funds recently made changes to their positions in the stock. Morgan Stanley boosted its stake in shares of Thermo Fisher Scientific by 5.0% in the fourth quarter. Morgan Stanley now owns 6,030,180 shares of the company’s stock valued at $855,382,000 after buying an additional 286,391 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Thermo Fisher Scientific by 2.4% in the fourth quarter. Principal Financial Group Inc. now owns 534,595 shares of the company’s stock valued at $75,832,000 after buying an additional 12,627 shares in the last quarter. UBS Oconnor LLC bought a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at about $1,277,000. Gulf International Bank UK Ltd boosted its stake in shares of Thermo Fisher Scientific by 2.4% in the fourth quarter. Gulf International Bank UK Ltd now owns 118,261 shares of the company’s stock valued at $16,775,000 after buying an additional 2,800 shares in the last quarter. Finally, Sawtooth Asset Management Inc. boosted its stake in shares of Thermo Fisher Scientific by 9,139.1% in the fourth quarter. Sawtooth Asset Management Inc. now owns 11,826 shares of the company’s stock valued at $1,678,000 after buying an additional 11,698 shares in the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.